Recap: Karyopharm Therapeutics Q4 Earnings

Karyopharm Therapeutics KPTI reported its Q4 earnings results on Tuesday, February 8, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Karyopharm Therapeutics beat estimated earnings by 193.88%, reporting an EPS of $0.46.

Revenue was up $91.17 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02, which was followed by a 0.38% increase in the share price the next day.

Here's a look at Karyopharm Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.